Carina A. Bernardo

Malmoe, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.

Journal: NPJ precision oncology

Published: January 09, 2026

Stage-Independent Real-Time Subtype Classification and Comprehensive Biopsy Profiling of Urothelial Carcinomas by the Lund Taxonomy System.

Stage-Independent Real-Time Subtype Classification and Comprehensive Biopsy Profiling of Urothelial Carcinomas by the Lund Taxonomy System.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: October 02, 2025

Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases.

Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases.

Journal: Experimental hematology & oncology

Published: April 02, 2025

Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer.

Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: December 05, 2024

Molecular Subtypes Are Associated With Clinical Benefit in Cisplatin-Treated Metastatic Urothelial Cancer Patients.

Molecular Subtypes Are Associated With Clinical Benefit in Cisplatin-Treated Metastatic Urothelial Cancer Patients.

Journal: JCO precision oncology

Published: September 30, 2024

A Versatile and Upgraded Version of the LundTax Classification Algorithm Applied to Independent Cohorts.

A Versatile and Upgraded Version of the LundTax Classification Algorithm Applied to Independent Cohorts.

Journal: The Journal of molecular diagnostics : JMD

Published: December 29, 2023

Restoring tumor immunogenicity with dendritic cell reprogramming.

Restoring tumor immunogenicity with dendritic cell reprogramming.

Journal: Science immunology

Published: July 07, 2023

Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer.

Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer.

Journal: International journal of cancer

Published: May 09, 2023

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection.

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection.

Journal: European urology open science

Published: May 09, 2023

Tumor Biomarkers for Bacillus Calmette-Guérin Response: What We Get Is Not What We Want.

Tumor Biomarkers for Bacillus Calmette-Guérin Response: What We Get Is Not What We Want.

Journal: European urology focus

Published: February 02, 2023

UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice - from biobank to RNA-sequencing in real time.

UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice - from biobank to RNA-sequencing in real time.

Journal: Scandinavian journal of urology

Published: December 21, 2022

The Lund taxonomy for bladder cancer classification - from gene expression clustering to cancer cell molecular phenotypes, and back again.

The Lund taxonomy for bladder cancer classification - from gene expression clustering to cancer cell molecular phenotypes, and back again.

Journal: The Journal of pathology

Published: November 18, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026